Trials / Recruiting
RecruitingNCT06229860
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (estimated)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Detailed description
The purpose of this pilot study is to explore the association between personality and adherence to a specific type of oral cancer medication - tyrosine kinase inhibitor (TKI) - in patients with chronic myeloid leukemia (CML). 75 individuals with chronic phase CML who are being treated with TKIs will be recruited. Consenting patients will participate in a focused interview where TKI adherence, personality type, and quality of life and symptom burden will be assessed using validated questionnaires. Information on treatment response and the treating physician's perception of TKI adherence will be obtained from the electronic health record.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Interview | In-person interview with the study coordinator to complete study questionnaire. |
Timeline
- Start date
- 2024-01-25
- Primary completion
- 2025-03-19
- Completion
- 2026-12-01
- First posted
- 2024-01-29
- Last updated
- 2026-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06229860. Inclusion in this directory is not an endorsement.